Founding Eagles guitarist Bernie Leadon says he's making music again and will release the new song 'Too Many Memories.' ...

NEWYou can now listen to Fox News articles!A federal judge ruled that a 76-year-old former Chicago alderman accused of ...

After the Veterans Health Administration tweaked its formulary on an asthma and chronic obstructive pulmonary disease therapy, hospitalizations and emergency department visits increased, according to ...

The CAAT governance board recommends transitioning from the COPD Assessment Test to the CAAT and using it for patients with ...

Home Energy Assistance Program Summer Crisis Program runs until Sept. 30. The program targets low-income households.

Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

The U.S. drug giant said that Verona’s Ohtuvayre, which treats chronic obstructive pulmonary disease, will strengthen its lineup of cardiovascular treatments.

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Health-care companies rose as deal activity offset more health-insurance controversy. Merck struck a roughly $10 billion deal to buy Verona Pharma, bolstering its lineup with the chronic obstructive ...

A rally in big tech stocks led Wall Street to a higher close, lifting the Nasdaq to another all-time high. The S&P 500 rose 0 ...